Genomic Claims You Can Trace

 Quick Analysis Plan Copied

CRISPR working principle: an RNA-guided nuclease (e.g., Cas9) uses a ~20-nt guide RNA to find a genomic target matching a PAM, then cuts both DNA strands via HNH and RuvC domains, triggering cellular repair (NHEJ/HDR) that enables genome editing; specificity depends on seed-sequence proximity to PAM, guide length, and chromatin accessibility [https://dx.doi.org/10.1038/ncomms14958, https://dx.doi.org/10.31857/s0026898423020155].

 Long Analysis Plan

Core Mechanism of CRISPR-Cas Genome Editing

CRISPR-Cas9 operates through a three-stage logic: (1) Recognition — a single-guide RNA pairs with a ~20-nucleotide genomic sequence adjacent to a PAM motif; (2) Cleavage — the Cas9 nuclease activates two catalytic domains (HNH cuts the target strand; RuvC cuts the non-target strand) creating a double-strand break; (3) Repair — cellular NHEJ or HDR fixes the break, enabling knockout or precise insertion [https://dx.doi.org/10.31857/s0026898423020155].

Key quantitative data from the sourced literature illustrate how proximal CRISPR targeting (proxy-CRISPR) modulates this mechanism by altering accessibility:

Summary chart of published measurements from https://dx.doi.org/10.1038/ncomms14958 across multiple loci (CAR, POR, EMX1, HBB) — values are observed data, not simulations.

Specificity Determinants

Specificity is governed by: seed-sequence proximity to the PAM, guide-RNA length, chromatin accessibility, and conformational proofreading via the REC2/REC3 lobe [https://dx.doi.org/10.31857/s0026898423020155]. Mismatch tolerance is higher at positions distal to the PAM, so mismatches near the seed region are more deleterious to binding and cleavage [https://dx.doi.org/10.31857/s0026898423020155].

Plan for Bioinformatics Analysis

• Target selection: identify candidate loci with a PAM-proximal seed and evaluate chromatin state (ATAC-seq, CpG methylation) as accessibility is a rate-limiting step for FnCas9 [https://dx.doi.org/10.1038/ncomms14958].
• Off-target prediction: run GUIDE-seq / Digenome-seq / CHANGE-seq pipelines to quantify genome-wide cleavage risk, factoring mismatch position and gRNA length [https://dx.doi.org/10.31857/s0026898423020155].
• Variant engineering: compare high-fidelity Cas9s (eSpCas9, SpCas9-HF1, HypaCas9, HiFi Cas9, xCas9) for specificity-efficiency trade-offs [https://dx.doi.org/10.31857/s0026898423020155].
• Proximal targeting (proxy-CRISPR): design dCas9 "proxy" sites 7 bp from the target to boost otherwise weak nucleases like FnCas9, CjCas9, NcCas9, or FnCpf1 [https://dx.doi.org/10.1038/ncomms14958].
• Repair-pathway modeling: model NHEJ vs HDR outcomes using loxP-integration fidelity data (33–48% precise ligation) [https://dx.doi.org/10.1038/ncomms14958].

Alternative CRISPR-Derived Systems

CRISPR-associated transposases (CASTs) exploit the same RNA-guided targeting logic but couple it to TnsB/TnsC-mediated transposition for DNA insertion without double-strand breaks — recent cryo-EM work resolved a sevenfold TnsC ring around the target DNA and allosteric activation of TnsB for site-specific integration [https://dx.doi.org/10.64898/2026.05.18.725949]. CRISPR-Cas12a/Cas13a systems are also being repurposed for nucleic-acid detection (e.g., ASFV diagnostics at 2 copies/µL sensitivity) rather than genome editing [https://dx.doi.org/10.3390/ani15131902].

Known Limitations and Open Questions

• Mechanism of how proximal dCas9 alters chromatin to enable FnCas9 access remains unresolved [https://dx.doi.org/10.1038/ncomms14958].
• Many off-target assessments rely on predicted rather than genome-wide exhaustive screens [https://dx.doi.org/10.1038/ncomms14958, https://dx.doi.org/10.31857/s0026898423020155].
• HRAMP-like derived systems (Cas5/Cas7 homologs, no CRISPR array) are proposed to function via RNA-dependent defense but lack experimental validation [https://dx.doi.org/10.1093/femsle/fnz079].
• Long-term clinical safety requires off-target rates comparable to background somatic mutation, an unresolved benchmark [https://dx.doi.org/10.31857/s0026898423020155].

Confidence: High for core recognition–cleavage–repair logic (multiple independent sources). Moderate for quantitative efficiency values, which vary by locus, cell type, and delivery method [https://dx.doi.org/10.1038/ncomms14958, https://dx.doi.org/10.31857/s0026898423020155].